Merck to Acquire Caraway Therapeutics for Close to $610 Mn in a Push for Neurodegenerative Disease Therapies November 23, 2023 The agreement includes earnout milestones linked to the development of specific pipeline candidates. Through its MRL Ventures Fund, Merck has been a shareholder in Caraway Therapeutics since 2018.
Cloudnine Inks MoU with BAPIO Training Academy to Foster Maternal, Other Training Programs November 22, 2023 Cloudnine Hospitals will invest in the training of its doctors specialising in maternity, fertility, and pediatrics through these programs. This initiative is introducing, for the first time in India, a program designed for MRCOG and MRCPCH exams.
Fortrea Partners with Medidata to Increase Diversity in Clinical Trials November 22, 2023 Under this new agreement, Fortrea will leverage the capabilities of Medidata AI Intelligent Trials, including features such as study feasibility and diversity data.
GBA Group Enters India with Stake Acquisition of Pharma Testing Startup Eureka November 22, 2023 The acquisition is expected to facilitate Eureka's expansion into the international market. The pharmaceutical startup also aims to enhance and scale its testing platforms, along with an emphasis on improving research and development initiatives.
AstraZeneca Introduces Evinova to Advance Global Digital Health Solutions for Enhanced Clinical Trials November 21, 2023 Evinova focuses on introducing globally-used digital solutions from AstraZeneca to optimise clinical trials, aiming to streamline new medicine development, improve patient care accessibility, and ease the burden on health systems.
SciBase Partners with Skin & Cancer Institute to Advance AI-Driven Skin Cancer Detection in California November 20, 2023 Nevisense is an AI-based point-of-care system for the non-invasive evaluation of atypical pigmented lesions. It is the only FDA-approved technology available for early melanoma detection in the US.